Goudsouzian N G, Young E T, Moss J, Liu L M
Br J Anaesth. 1986 Nov;58(11):1229-33. doi: 10.1093/bja/58.11.1229.
The histamine releasing potential of equivalent bolus doses of atracurium 0.6 mg kg-1 or vecuronium 0.12 mg kg-1 was evaluated in 20 children anaesthetized with halothane. Blood samples were obtained before, and at 2 and 5 min after the administration of the neuromuscular blocker. The twitch response to 0.15 Hz was also evaluated. None of the 10 patients receiving vecuronium had a significant increase in plasma histamine concentration. In two of the 10 children receiving atracurium, the plasma histamine concentration increased markedly, but without any apparent clinical manifestations. Recovery of neuromuscular function (to 95% twitch height) after vecuronium 0.12 mg kg-1 was faster than after atracurium 0.6 mg kg-1 (P less than 0.02).
在20名接受氟烷麻醉的儿童中,评估了等效推注剂量的阿曲库铵0.6毫克/千克或维库溴铵0.12毫克/千克释放组胺的潜力。在给予神经肌肉阻滞剂之前、给药后2分钟和5分钟采集血样。还评估了对0.15赫兹的抽搐反应。接受维库溴铵的10名患者中,血浆组胺浓度均无显著升高。在接受阿曲库铵的10名儿童中,有两名儿童的血浆组胺浓度显著升高,但无任何明显临床表现。0.12毫克/千克维库溴铵后神经肌肉功能恢复至(抽搐高度的)95%比0.6毫克/千克阿曲库铵后更快(P小于0.02)。